BBVA

Stronger trading gains and accelerated cost of risk normalisation

30/04/21 -"The quarter was marked by the deconsolidation of the US operations, albeit the accretive impact on the capital position still has to be factored in. It enjoyed strong CIB revenues and accelerated ..."

PDF page sample
Pages
57
Language
English
Published on
30/04/21
Download
You may also be interested by these reports :
07/05/21
Following the Q1 21 earnings release, we are sharply revising upwards our EPS going into 2021 and 2022. Part of the increase comes from lower loan ...
07/05/21
CASA released this morning its numbers for Q1 21. In absolute terms, these are above expectations and are proving CASA’s ability to grow its top line ...
07/05/21
• Net profit attributable to shares increased by 20% to €193m for Q1 21 • Loan loss provisions were down by 49% to €79m (35bp) for Q1 21 • Outlook ...
06/05/21
ING Group released this morning its numbers for Q1 21. Net profit was 31% above expectations, driven by lower loan losses (expected) and higher net ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO